Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SSX2 anticorps (C-Term)

SSX2 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2780224
  • Antigène Voir toutes SSX2 Anticorps
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Épitope
    • 15
    • 7
    • 6
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    C-Term
    Reactivité
    • 48
    • 3
    • 2
    Humain
    Hôte
    • 42
    • 6
    Lapin
    Clonalité
    • 45
    • 3
    Polyclonal
    Conjugué
    • 20
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp SSX2 est non-conjugé
    Application
    • 33
    • 13
    • 13
    • 9
    • 6
    • 5
    • 4
    • 4
    • 3
    • 1
    • 1
    Western Blotting (WB)
    Séquence
    HRWSSQNTHN IGRFSLSTSM GAVHGTPKTI THNRDPKGGN MPGPTDCVRE
    Homologie
    Human: 100%
    Attributs du produit
    This is a rabbit polyclonal antibody against SSX2. It was validated on Western Blot using a cell lysate as a positive control.
    Purification
    Affinity Purified
    Immunogène
    The immunogen is a synthetic peptide directed towards the C terminal region of human SSX2
    Top Product
    Discover our top product SSX2 Anticorps primaire
  • Indications d'application
    Optimal working dilutions should be determined experimentally by the investigator.
    Commentaires

    Antigen size: 223 AA

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    Lot specific
    Buffer
    Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Conseil sur la manipulation
    Avoid repeated freeze-thaw cycles.
    Stock
    -20 °C
    Stockage commentaire
    For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
  • Jung, Fischer, Imig, Kleber, Nuber, Reinshagen, Kamradt, Grobholz, Knuth, Renner, Wadle: "Yeast-based identification of prostate tumor antigens provides an effective vaccine platform." dans: Anticancer research, Vol. 30, Issue 3, pp. 895-902, (2010) (PubMed).

  • Antigène
    SSX2 (Synovial Sarcoma, X Breakpoint 2 (SSX2))
    Autre désignation
    SSX2 (SSX2 Produits)
    Synonymes
    anticorps CT5.2, anticorps CT5.2A, anticorps HD21, anticorps HOM-MEL-40, anticorps SSX, anticorps SSX2, anticorps SSX3, anticorps SSX family member 2, anticorps protein SSX2, anticorps synovial sarcoma, X breakpoint 2, anticorps SSX2, anticorps LOC741661, anticorps Ssx2
    Sujet
    SSX2 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene.The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This translocation results in the fusion of the synovial sarcoma translocation gene on chromosome 18 to one of the SSX genes on chromosome X. The encoded hybrid proteins are probably responsible for transforming activity. Two transcript variants encoding distinct isoforms have been identified for this gene.
    Alias Symbols: HD21, HOM-MEL-40, MGC119055, MGC15364, MGC3884, SSX, SSX2B, CT5.2a
    Protein Interaction Partner: KRT40, SSX2IP, RAB3IP, SYCE1, ZMIZ2, MAGEC2, AKAP9, ZBED1, TAX1BP1, BLZF1, SUZ12, EED, SMARCA5, TLE1, SMARCA2, HDAC2, HDAC1, EZH2, ATF2, RNF2,
    Protein Size: 223
    Poids moléculaire
    25 kDa
    ID gène
    6757
    NCBI Accession
    NM_003147, NP_003138
Vous êtes ici:
Support technique